Veristat Formalizes its Strategic Decision Consulting Services
SOUTHBOROUGH, MA – November 01, 2016 – Veristat, a full-service consultative Clinical Research Organization (CRO), announced today the formal...
Veristat Strengthens Its Long-Standing Relationship with Aegerion Pharmaceuticals
Veristat, a full service Clinical Research Organization (CRO), announced today the signing of a Preferred Provider Agreement (PPA) with ...
Veristat Acknowledged for its Rapid Growth on the Inc. 5000 List of America’s...
Veristat Continues To Be Recognized for Its Positive Impact & Company Growth
SOUTHBOROUGH, MA – August 17, 2016 – Veristat announced today...
Veristat Article “Adaptive Designs- Recent Advancement in Clinical Trials” Published in...
Two of Veristat’s statistical and adaptive design experts submitted a research paper which was published in the June 2016 issue of the ...
Fueled by Growth, Veristat Continues Geographic Expansion in North Carolina
Accelerates Hiring & Plans to Open Office in Raleigh-Durham, North Carolina
Veristat Strengthens Statistical Consulting and Adaptive Design Trial Expertise With...
Appoints Mark Chang as Senior Vice President of Strategic Statistical Consulting
SOUTHBOROUGH, MA – June 15, 2016 – Veristat, a full...
Veristat Expands Its Clinical Operations into Europe - Acquires UK-based CRO, Spero Oncology
SOUTHBOROUGH, MA – May 2, 2016 – Veristat, a full service Clinical Research Organization (CRO), announced today that it is expanding its...
Veristat Ranked #35 on Boston Business Journal’s “Fast 50” List, the Top 50 Fastest Growing...
Veristat Recognized as One of the Top 50 Fastest-Growing Private Companies in Massachusetts
Veristat, a full service Clinical Research...
Veristat Named as One of the Fastest Growing Private Companies in Massachusetts by Boston...
Veristat joins the Boston Business Journal’s 2016 Fast 50 (Formerly Pacesetters) list. This is the list of the fastest growing private...